Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry A Filimonov

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Molecules (Basel, Switzerland)|July 2, 2020
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1Olga Tarasova, Sergey Ivanov, Dmitry A Filimonov, et al.
Computational Biology and Chemistry|April 4, 2024
Prediction of viral protease inhibitors using proteochemometrics approachDmitry A Karasev, Boris N Sobolev, Dmitry A Filimonov, et al.
Chemical Research in Toxicology|October 20, 2012
Quantitative prediction of antitarget interaction profiles for chemical compoundsAlexey V Zakharov, Alexey A Lagunin, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|February 11, 2023
SAV-Pred: A Freely Available Web Application for the Prediction of Pathogenic Amino Acid Substitutions for Monogenic Hereditary Diseases Studied in Newborn ScreeningAnton D Zadorozhny, Anastasia V Rudik, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|December 17, 2024
Prediction of Protein Secondary Structures Based on Substructural Descriptors of Molecular FragmentsOleg S Zakharov, Anastasia V Rudik, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|October 14, 2020
Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human BodyDmitry A Filimonov, Anastassia V Rudik, Alexander V Dmitriev, et al.
Chemical Research in Toxicology|February 16, 2022
Relationships between the Structure and Severe Drug-Induced Liver Injury for Low, Medium, and High Doses of DrugsSergey M Ivanov, Alexey A Lagunin, Dmitry A Filimonov, et al.
Immunology|March 17, 2023
TCR-Pred: A new web-application for prediction of epitope and MHC specificity for CDR3 TCR sequences using molecular fragment descriptorsAnton S Smirnov, Anastasia V Rudik, Dmitry A Filimonov, et al.
Molecules (Basel, Switzerland)|December 29, 2019
(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like CompoundsLeonid A Stolbov, Dmitry S Druzhilovskiy, Dmitry A Filimonov, et al.
Viruses|July 27, 2024
Quantitative Prediction of Human Immunodeficiency Virus Drug ResistanceEkaterina A Stolbova, Leonid A Stolbov, Dmitry A Filimonov, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|July 2, 2020
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1Olga Tarasova, Sergey Ivanov, Dmitry A Filimonov, et al.
Computational Biology and Chemistry|April 4, 2024
Prediction of viral protease inhibitors using proteochemometrics approachDmitry A Karasev, Boris N Sobolev, Dmitry A Filimonov, et al.
Chemical Research in Toxicology|October 20, 2012
Quantitative prediction of antitarget interaction profiles for chemical compoundsAlexey V Zakharov, Alexey A Lagunin, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|February 11, 2023
SAV-Pred: A Freely Available Web Application for the Prediction of Pathogenic Amino Acid Substitutions for Monogenic Hereditary Diseases Studied in Newborn ScreeningAnton D Zadorozhny, Anastasia V Rudik, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|December 17, 2024
Prediction of Protein Secondary Structures Based on Substructural Descriptors of Molecular FragmentsOleg S Zakharov, Anastasia V Rudik, Dmitry A Filimonov, et al.
International Journal of Molecular Sciences|October 14, 2020
Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human BodyDmitry A Filimonov, Anastassia V Rudik, Alexander V Dmitriev, et al.
Chemical Research in Toxicology|February 16, 2022
Relationships between the Structure and Severe Drug-Induced Liver Injury for Low, Medium, and High Doses of DrugsSergey M Ivanov, Alexey A Lagunin, Dmitry A Filimonov, et al.
Immunology|March 17, 2023
TCR-Pred: A new web-application for prediction of epitope and MHC specificity for CDR3 TCR sequences using molecular fragment descriptorsAnton S Smirnov, Anastasia V Rudik, Dmitry A Filimonov, et al.
Molecules (Basel, Switzerland)|December 29, 2019
(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like CompoundsLeonid A Stolbov, Dmitry S Druzhilovskiy, Dmitry A Filimonov, et al.
Viruses|July 27, 2024
Quantitative Prediction of Human Immunodeficiency Virus Drug ResistanceEkaterina A Stolbova, Leonid A Stolbov, Dmitry A Filimonov, et al.
Pageof 5